-
In severe aortic stenosis (AS) with symptoms, aortic valve replacement is recommended.
-
Patients with diabetes have twice the stroke risk of those without diabetes.
-
Beta-blockers are widely considered first-line therapy for heart rate control in patients with permanent atrial fibrillation (AF), but few comparative effectiveness data with other drugs are available.
-
The accurate and timely recognition of acute coronary syndromes (ACS) may facilitate the deployment of evidence-based therapies that could impact outcomes.
-
Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions.
-
This study examines the influence of renal dysfunction on stroke risks in two atrial fibrillation (AF) study groups. The ROCKET AF trial was a trial comparing fixed-dose rivaroxaban, a direct factor Xa inhibitor, with adjusted-dose warfarin for prevention of thromboembolic events.
-
The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial randomized 1376 patients with AF and CHF to rhythm- or rate-control treatment strategies.
-
Saphenous vein graft patency after coronary artery bypass grafting failure rates are as high as 40% at 18 months. How many of these failures are due to the discontinuation of clopidogrel is the subject of this observational study done at a regional heart center in the Southern California Kaiser system that includes detailed pharmacy records.
-
This paper reviews the experience at a large cardiac surgery center with ventricular arrhythmias in the postoperative period. The authors searched the Society of Thoracic Surgeons (STS) adult cardiac database for all patients undergoing cardiac surgery at Emory University between January 2004 and July 2010.
-
Autopsy studies from the Korea and Vietnam wars, which demonstrated that atherosclerosis begins in teens and young adults, have revolutionized our understanding of the pathogenesis and progression of coronary artery disease (CAD).